Rossari Biotech Share Price
459.70+2.70 (+0.59%)
-27.61% past 1 Year
News
Rossari Biotech prioritises KSA project, limits India capex in FY27–FY28
Equity
ROSSARI
Rossari Biotech projects Rs 30-50 crores FY27 pharma revenue ramp-up
Equity
ROSSARI
Rossari Biotech targets margin improvement via portfolio optimisation and capacity utilisation
Equity
ROSSARI
Rossari Biotech sets Q1 FY27 EBITDA margin baseline, targets 15 percent plus in 2 years
Equity
ROSSARI
Rossari Biotech upbeat on FY28 growth outlook on improved EO availability
Equity
ROSSARI
Rossari Biotech maintains FY27 topline growth guidance despite strong Q1 performance
Equity
ROSSARI
Rossari Biotech flags El Nino-led challenges for agriculture segment outlook
Equity
ROSSARI
Rossari Biotech faces uncertain revenue and profit growth outlook amid global headwinds
Equity
ROSSARI
Rossari Biotech Q1 EBITDA rises year-on-year but margin moderates slightly
Equity
ROSSARI
Rossari Biotech Q1 revenue rises year-on-year, strong topline momentum continues
Equity
ROSSARI
Rossari Biotech Q1 FY26 consolidated net profit edges higher YoY
Equity
ROSSARI
Rossari Biotech to host Q1 earnings conference call on July 20 at 5 PM
Equity
ROSSARI
Rossari Biotech - Quaterly Results
Equity
ROSSARI
Rossari Biotech Q4 EBITDA Rises 11% YoY to Rs 77.20 Crores, Margin at 11.28%
Equity
ROSSARI
Rossari Biotech Q4FY26 Net Profit Rises 33.6% YoY to Rs 46 Cr, Revenue Up 20.7% to Rs 700 Cr.
Equity
ROSSARI
Rossari Biotech reports Profit after tax of 54.73 Crores, in the March 2026 quarter
Equity
ROSSARI
Rossari Biotech informs about disclosure
Equity
ROSSARI
Rossari Biotech informs about updates
Equity
ROSSARI
Rossari Biotech Outlines Priorities for Capacity Utilization, Product Portfolio, Financial Discipline in Concall.
Equity
ROSSARI
Rossari Biotech Board Approves Greenfield Specialty Chemicals Facility in Saudi Arabia.
Equity
ROSSARI